Developer docs
API playgroundTry for free, no card

Search company profiles

Repolar Pharmaceuticals

Full company profile

uuid000cbav

Namestring
Repolar Pharmaceuticals
Legal namestring
Repolar Pharmaceuticals Oy
Websiteurl
repolar.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Repolar Pharmaceuticals Oy is a Finnish private drug manufacturer founded in 2006 (with R&D dating to 2000) that develops, manufactures, and markets resin-based care products for humans and animals. The company is headquartered in Espoo, Finland with an operations office in Kolari (Finnish Lapland) near its raw material sourcing area, and operates with 1-10 employees. Repolar's products target wound care (acute and chronic wounds, pressure sores, diabetic wounds, leg ulcers, surgical wounds, burns), nail fungus, acne, and scalp/hair care in humans, and wound, ear, skin, and dental care in animals. Named brands include Abilar (wound salve), Abicin (nail lacquer), AbiCare (skincare), and the Ani series (AniVox, Abilar VET, AniWipe, AniDes, AniWash, AniLavo, AniPlax).

The company's core technology is its patented Resol Technology, a proprietary method for processing Norway spruce (Picea abies) resin collected by hand in northern Lapland into stable, water-soluble, non-sticky liquid solutions while preserving natural broad-spectrum antimicrobial properties. Cold-cleaned raw resin, supplemented by in vitro efficacy data against bacteria including MRSA and VRE and against dermatophytes, supports claims of effectiveness without antibiotics or cortisone. The company holds ISO 13485 certification for medical device design and manufacture, Finnish Key Flag (Avainlippu) designation, and has a body of peer-reviewed clinical and dermatology publications.

Commercially, Repolar sells through OTC pharmacy channels in Finland, veterinary clinics for animal products, and Finnish hospitals/health centres for professional wound care, with export distribution via Apotek1 in Norway. Revenue is generated through one-time product sales (no subscription or licensing disclosed) at undisclosed price points. The company is family-owned (Sipponen family and colleagues), has no disclosed external funding, and operates with an export sales director, R&D/quality manager, marketing team, and production technician, signaling a small but functional commercial infrastructure oriented toward incremental Nordic expansion.

Short descriptiontext

Repolar Pharmaceuticals Oy is a Finnish private drug manufacturer (founded 2006) that develops and sells resin-based wound care, nail fungus, skincare, and animal care products built on its patented Resol Technology, distributed through pharmacies, veterinary clinics, and hospitals in Finland and Norway.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersEspoo, Finland
HQ citystring
Espoo
HQ countrystring
Finland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
resin-based wound care, topical antimicrobial products, natural pharmaceuticals, veterinary skin care, medical device salve
Industry2 codes
PRIMARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAMAFAF
Wound Care, Bandaging & Consumables (Dressings, Sutures, Staplers)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Medical Devices & Supplies
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Medicinal Chemicals & Botanical Products2833
Product category
Topical Wound and Skin Care Pharmaceuticals
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Pharmaceutical/Medical Device Product Sales
TypeOne Time License
Description

One-time purchase model for medical products including wound care (Abilar), nail fungus treatment (Abicin), and acne care (AbiCare) for humans, plus animal care products (Ani series). Products sold through pharmacy and veterinary clinic distribution channels.

repolar.com
2Animal Care Product Sales
TypeOne Time License
Description

Resin-based veterinary products including wound sprays, ear washes, shampoos, and dental care sold through animal clinics and pharmacies.

repolar.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 10 records shown
1Abilar
Description

Resin-based wound care product line for humans and animals

repolar.com
+9 more records
Core offering1 text field

Repolar Pharmaceuticals researches, develops, manufactures and markets resin-based care products for humans and animals derived from Norway spruce (Picea abies) resin. Its product portfolio spans wound care salves (Abilar), nail fungus lacquer (Abicin), acne and scalp care (AbiCare), and a full veterinary line (Ani series — ear wash, wound spray, shampoo, wipes, dental care, rinsing liquid). Products are sold over-the-counter through pharmacies and veterinary clinics in Finland and selected Nordic markets.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Clinical studies show effective treatment of pressure ulcers, diabetic wounds, and complicated surgical wounds
+2 more records
Product and service3 records
1Abilar® 10% Resin Salve (Wound Balm)
CategoryWound care
Description

10% Norway spruce resin salve for treatment of acute and chronic wounds, pressure sores, diabetic wounds, leg ulcers, complicated surgical wounds, and burn wounds. For human use; sold over-the-counter in pharmacies.

2Abicin® 30% Resin Lacquer
CategoryNail fungus treatment
Description

30% Norway spruce resin lacquer for the treatment of nail fungus infections and paronychia. Sold over-the-counter in pharmacies.

3AbiCare® Acne Cream
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Luonnonperintösäätiö (Nature Heritage Foundation)
Strategic tierMinorTypeOthers
Description

Partnership for forest conservation in North Ostrobothnia, Finland. For each Abilar resin salve sold, 1 square meter of Finnish forest is protected. Campaign to preserve old-growth forests and biodiversity in northern Finland.

repolar.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeRegional player
Description

Finnish ingredient and finished-products company specializing in natural, plant-derived health and skin care formulations. Thematically comparable as a fellow Finnish/Nordic natural-ingredient pharma and personal-care player, though with a different active-ingredient focus than Repolar's spruce resin.

TypeBroad incumbent
Description

Global dermatology pharmaceutical company (Differin, Epiduo, Benzac) with strong acne and skin-condition franchises. Comparable to Repolar's AbiCare acne/scalp line and indicative of the larger dermatology landscape Repolar's branded products compete within.

TypeDirect peer
Description

Danish medical device company with a major wound and skin care franchise (Biatain, Comfeel) sold through pharmacies and hospitals. Highly comparable in business model and OTC wound/skin category overlap with Repolar's Abilar line.

TypeDirect peer
Description

French independent animal health company covering companion and livestock pharmaceuticals including dermatology and wound care. Comparable in vet-channel focus and product overlap with Repolar's Ani-series veterinary wound and ear care products.

TypeDirect peer
Description

Swedish-headquartered global leader in advanced wound care (Mepilex, Mepitel, Avance) and surgical solutions. Direct comparability to Repolar's wound-care franchise (Abilar resin salve for pressure ulcers, diabetic wounds, surgical wounds) with much larger scale.

TypeDirect peer
Description

France-based global animal health company with a strong dermatology, ear care, and wound care portfolio for companion animals. Directly comparable business model and product categories to Repolar's AniVox, AniDes, AniWash lines.

TypeDirect peer
Description

UK-listed medtech company focused on advanced wound care, ostomy, continence and infusion care. Comparable to Repolar in its wound-care focus and OTC/professional channel strategy across European markets.

TypeDirect peer
Description

UK-listed veterinary pharmaceuticals specialist with deep coverage of companion and equine animal health, including dermatology and wound care. Closely comparable to Repolar's Ani-series in animal wound/skin/ear care and channel mix of vet clinics plus pharmacies.

TypeBroad incumbent
Description

Global medical devices company with a sizable Advanced Wound Management portfolio (Acticoat, Allevyn, PICO). A broad incumbent whose wound-care franchise overlaps with Repolar's professional-use claims and competes for hospital formulary slots.

10Bayer Consumer Health
TypeBroad incumbent
Description

OTC healthcare giant behind Canesten (nail fungus) and Bepanthen (wound/skin care), directly competitive with Repolar's Abicin and Abilar lines in European pharmacies. A broad incumbent where overlap is partial but highly relevant to Repolar's core categories.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Repolar Pharmaceuticals

Topical Wound and Skin Care Pharmaceuticalsrepolar.com

Repolar Pharmaceuticals Oy is a Finnish private drug manufacturer (founded 2006) that develops and sells resin-based wound care, nail fungus, skincare, and animal care products built on its patented Resol Technology, distributed through pharmacies, veterinary clinics, and hospitals in Finland and Norway.

What Repolar Pharmaceuticals does

Repolar Pharmaceuticals Oy is a Finnish private drug manufacturer founded in 2006 (with R&D dating to 2000) that develops, manufactures, and markets resin-based care products for humans and animals. The company is headquartered in Espoo, Finland with an operations office in Kolari (Finnish Lapland) near its raw material sourcing area, and operates with 1-10 employees. Repolar's products target wound care (acute and chronic wounds, pressure sores, diabetic wounds, leg ulcers, surgical wounds, burns), nail fungus, acne, and scalp/hair care in humans, and wound, ear, skin, and dental care in animals. Named brands include Abilar (wound salve), Abicin (nail lacquer), AbiCare (skincare), and the Ani series (AniVox, Abilar VET, AniWipe, AniDes, AniWash, AniLavo, AniPlax).

The company's core technology is its patented Resol Technology, a proprietary method for processing Norway spruce (Picea abies) resin collected by hand in northern Lapland into stable, water-soluble, non-sticky liquid solutions while preserving natural broad-spectrum antimicrobial properties. Cold-cleaned raw resin, supplemented by in vitro efficacy data against bacteria including MRSA and VRE and against dermatophytes, supports claims of effectiveness without antibiotics or cortisone. The company holds ISO 13485 certification for medical device design and manufacture, Finnish Key Flag (Avainlippu) designation, and has a body of peer-reviewed clinical and dermatology publications.

Commercially, Repolar sells through OTC pharmacy channels in Finland, veterinary clinics for animal products, and Finnish hospitals/health centres for professional wound care, with export distribution via Apotek1 in Norway. Revenue is generated through one-time product sales (no subscription or licensing disclosed) at undisclosed price points. The company is family-owned (Sipponen family and colleagues), has no disclosed external funding, and operates with an export sales director, R&D/quality manager, marketing team, and production technician, signaling a small but functional commercial infrastructure oriented toward incremental Nordic expansion.

Repolar Pharmaceuticals firmographics

Firmographics
Name
Repolar Pharmaceuticals
Legal name
Repolar Pharmaceuticals Oy
Website
https://repolar.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
Repolar Pharmaceuticals Oy is a Finnish private drug manufacturer (founded 2006) that develops and sells resin-based wound care, nail fungus, skincare, and animal care products built on its patented Resol Technology, distributed through pharmacies, veterinary clinics, and hospitals in Finland and Norway.
Ownership category
akta.pro rank

Repolar Pharmaceuticals industry classification

Industry
Product category
Topical Wound and Skin Care Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
SIC
Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAMAFAF
Wound Care, Bandaging & Consumables (Dressings, Sutures, Staplers)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Medical Devices & Supplies

Keywords

  • Resin-based wound care
  • Topical antimicrobial products
  • Natural pharmaceuticals
  • Veterinary skin care
  • Medical device salve

Where Repolar Pharmaceuticals is headquartered

Location

Headquarters

HQ city
Espoo
HQ country
Finland
HQ region
Europe

Offices2 records

Markets served

Repolar Pharmaceuticals business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Pharmaceutical/Medical Device Product Sales: One-time purchase model for medical products including wound care (Abilar), nail fungus treatment (Abicin), and acne care (AbiCare) for humans, plus animal care products (Ani series). Products sold through pharmacy and veterinary clinic distribution channels.
  2. Animal Care Product Sales: Resin-based veterinary products including wound sprays, ear washes, shampoos, and dental care sold through animal clinics and pharmacies.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Repolar Pharmaceuticals product offering

Product offering

Core offering

Repolar Pharmaceuticals researches, develops, manufactures and markets resin-based care products for humans and animals derived from Norway spruce (Picea abies) resin. Its product portfolio spans wound care salves (Abilar), nail fungus lacquer (Abicin), acne and scalp care (AbiCare), and a full veterinary line (Ani series — ear wash, wound spray, shampoo, wipes, dental care, rinsing liquid). Products are sold over-the-counter through pharmacies and veterinary clinics in Finland and selected Nordic markets.

Differentiator

Problem solved

Functional benefit

Brands

  • Abilar: Resin-based wound care product line for humans and animals
  • Abicin
  • AbiCare
  • AniVox
  • AniWipe
  • AniDes
  • AniWash
  • AniLavo
  • AniPlax
  • Resol

Products and services

  • Abilar® 10% Resin Salve (Wound Balm) 10% Norway spruce resin salve for treatment of acute and chronic wounds, pressure sores, diabetic wounds, leg ulcers, complicated surgical wounds, and burn wounds. For human use; sold over-the-counter in pharmacies.
  • Abicin® 30% Resin Lacquer 30% Norway spruce resin lacquer for the treatment of nail fungus infections and paronychia. Sold over-the-counter in pharmacies.
  • AbiCare® Acne Cream

Quantifiable outcome

  • Clinical studies show effective treatment of pressure ulcers, diabetic wounds, and complicated surgical wounds
  • +2 more outcomes

Companies that use Repolar Pharmaceuticals

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Repolar Pharmaceuticals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Repolar Pharmaceuticals partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Luonnonperintösäätiö (Nature Heritage Foundation)minorOthersPartnership for forest conservation in North Ostrobothnia, Finland. For each Abilar resin salve sold, 1 square meter of Finnish forest is protected. Campaign to preserve old-growth forests and biodiversity in northern Finland.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Repolar Pharmaceuticals competitors and assessment

Company assessment

Regional players

  • Aromtech: Finnish ingredient and finished-products company specializing in natural, plant-derived health and skin care formulations. Thematically comparable as a fellow Finnish/Nordic natural-ingredient pharma and personal-care player, though with a different active-ingredient focus than Repolar's spruce resin.

Broad incumbents

  • Galderma: Global dermatology pharmaceutical company (Differin, Epiduo, Benzac) with strong acne and skin-condition franchises. Comparable to Repolar's AbiCare acne/scalp line and indicative of the larger dermatology landscape Repolar's branded products compete within.
  • Smith & Nephew: Global medical devices company with a sizable Advanced Wound Management portfolio (Acticoat, Allevyn, PICO). A broad incumbent whose wound-care franchise overlaps with Repolar's professional-use claims and competes for hospital formulary slots.
  • Bayer Consumer Health: OTC healthcare giant behind Canesten (nail fungus) and Bepanthen (wound/skin care), directly competitive with Repolar's Abicin and Abilar lines in European pharmacies. A broad incumbent where overlap is partial but highly relevant to Repolar's core categories.

Direct peers

  • Coloplast: Danish medical device company with a major wound and skin care franchise (Biatain, Comfeel) sold through pharmacies and hospitals. Highly comparable in business model and OTC wound/skin category overlap with Repolar's Abilar line.
  • Vetoquinol: French independent animal health company covering companion and livestock pharmaceuticals including dermatology and wound care. Comparable in vet-channel focus and product overlap with Repolar's Ani-series veterinary wound and ear care products.
  • Mölnlycke Health Care: Swedish-headquartered global leader in advanced wound care (Mepilex, Mepitel, Avance) and surgical solutions. Direct comparability to Repolar's wound-care franchise (Abilar resin salve for pressure ulcers, diabetic wounds, surgical wounds) with much larger scale.
  • Virbac: France-based global animal health company with a strong dermatology, ear care, and wound care portfolio for companion animals. Directly comparable business model and product categories to Repolar's AniVox, AniDes, AniWash lines.
  • ConvaTec: UK-listed medtech company focused on advanced wound care, ostomy, continence and infusion care. Comparable to Repolar in its wound-care focus and OTC/professional channel strategy across European markets.
  • Dechra Pharmaceuticals: UK-listed veterinary pharmaceuticals specialist with deep coverage of companion and equine animal health, including dermatology and wound care. Closely comparable to Repolar's Ani-series in animal wound/skin/ear care and channel mix of vet clinics plus pharmacies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Repolar Pharmaceuticals social profiles

Digital presence

Repolar Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Repolar Pharmaceuticals leadership team

Management profile

Number of profiles

Profiles9 records

Repolar Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Repolar Pharmaceuticals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Repolar Pharmaceuticals

What does Repolar Pharmaceuticals do?

Repolar Pharmaceuticals researches, develops, manufactures and markets resin-based care products for humans and animals derived from Norway spruce (Picea abies) resin. Its product portfolio spans wound care salves (Abilar), nail fungus lacquer (Abicin), acne and scalp care (AbiCare), and a full veterinary line (Ani series — ear wash, wound spray, shampoo, wipes, dental care, rinsing liquid). Products are sold over-the-counter through pharmacies and veterinary clinics in Finland and selected Nordic markets.

Is Repolar Pharmaceuticals a public or private company?

Repolar Pharmaceuticals is a private company. It is classified as family owned and is currently operating.

When was Repolar Pharmaceuticals founded?

Repolar Pharmaceuticals was founded in 2006. It employs 11 to 50 people.

Where is Repolar Pharmaceuticals based?

Repolar Pharmaceuticals is headquartered in Espoo, Finland, in the Europe region.

How does Repolar Pharmaceuticals make money?

Two revenue lines are on record. Pharmaceutical/Medical Device Product Sales are the primary driver. The others are animal Care Product Sales.

Who are Repolar Pharmaceuticals's main competitors?

Aromtech is listed as a regional player. Broad incumbents are Galderma, Smith & Nephew and Bayer Consumer Health. Direct peers are Coloplast, Vetoquinol, Mölnlycke Health Care, Virbac, ConvaTec and Dechra Pharmaceuticals.

Does Repolar Pharmaceuticals have an API?

No public API is recorded for Repolar Pharmaceuticals.

What industry is Repolar Pharmaceuticals in?

Repolar Pharmaceuticals's product category is Topical Wound and Skin Care Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals, with a secondary code of HLAMAFAF, Wound Care, Bandaging & Consumables (Dressings, Sutures, Staplers). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals